2024 - Women’s Health Awareness Month: The Evolving Women’s Health Clinical Development Landscape
Date2024-05-28
Deadline2024-05-28
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Clinical Trials; Patient Recruitment & Retention
Topics/Call fo Papers
Learn from industry experts about the dynamic landscape of clinical development related to Women’s Health and obtain key insights into its unique medical and operational aspects. Right from study design and site selection to recruitment, retention and operational strategies, this webinar will provide actionable insights that can drive impactful research outcomes.
May is recognized as National Women’s Health Awareness Month, highlighting the unique challenges and disparities that women face globally in healthcare. Despite comprising around half of the world’s population, women have historically been understudied and underrepresented in clinical research, leading to significant gaps in knowledge and treatment options.
However, amidst the recent biotech slowdown, clinical development related to Women’s Health has garnered increasing attention in recent years. Venture capital funding for Women’s Health is increasing, driven by US Food and Drug Administration (FDA) and White House initiatives focused on research related to Women’s Health.
The expert panel will explore the past, present and future of Women’s Health clinical research, addressing common misconceptions and highlighting significant opportunities for investment and innovation. The discussion will span the entire spectrum of women’s health needs across the life cycle, ranging from adolescent to post-menopausal gynecologic needs.
Do not miss the opportunity to gain expert guidance and contribute to the advancement of clinical development related to Women’s Health on a global scale. Register now and help in shaping the future of healthcare for women worldwide.
Keywords: Clinical Trials, Clinical Research, CRO, Patient Recruitment, Therapeutic Areas, Patient Retention, Patient Enrollment, Women's Health, Patient Diversity, Clinical Trial Diversity
May is recognized as National Women’s Health Awareness Month, highlighting the unique challenges and disparities that women face globally in healthcare. Despite comprising around half of the world’s population, women have historically been understudied and underrepresented in clinical research, leading to significant gaps in knowledge and treatment options.
However, amidst the recent biotech slowdown, clinical development related to Women’s Health has garnered increasing attention in recent years. Venture capital funding for Women’s Health is increasing, driven by US Food and Drug Administration (FDA) and White House initiatives focused on research related to Women’s Health.
The expert panel will explore the past, present and future of Women’s Health clinical research, addressing common misconceptions and highlighting significant opportunities for investment and innovation. The discussion will span the entire spectrum of women’s health needs across the life cycle, ranging from adolescent to post-menopausal gynecologic needs.
Do not miss the opportunity to gain expert guidance and contribute to the advancement of clinical development related to Women’s Health on a global scale. Register now and help in shaping the future of healthcare for women worldwide.
Keywords: Clinical Trials, Clinical Research, CRO, Patient Recruitment, Therapeutic Areas, Patient Retention, Patient Enrollment, Women's Health, Patient Diversity, Clinical Trial Diversity
Other CFPs
- Pharmacokinetic/Pharmacodynamic (PKPD) Data Analysis and Sample Tracking
- Advancing CGT Trial Ecosystems in the Asia-Pacific Region
- Unlocking Evidence-Based Ingredients for Active Nutrition, Executive Function, eSports and Optimal Lifespan
- Is Clinical Supply the Weakest Link in Your Chain?
- Navigating the Landscape of Complex & Adaptive Oncology Trials: Key Challenges & Solutions
Last modified: 2024-05-16 02:48:49